Navigation Links


SYBR at Biology News

SYBR at Biology Products

SYBR Green II RNA gel stain*10,000X concentrate in DMSO* from Molecular Probes (Invitrogen)

Description:is a sensitive nucleic acid gel stain that has bright fluorescence when bound to RNA and low background in gels, making it ideal for use with either formaldehyde/agarose or polyacrylamide gels using laser scanners or standard UV transilluminators. One mL stains 100 minigels. A 500 µL unit size (S-7564) and a special packaging (S-7586) are available....
Company:Molecular Probes (Invitrogen)

SYBR Green II RNA gel stain*10,000X concentrate in DMSO* from Molecular Probes (Invitrogen)

Description:is a sensitive nucleic acid gel stain that has bright fluorescence when bound to RNA and low background in gels, making it ideal for use with either formaldehyde/agarose or polyacrylamide gels using laser scanners or standard UV transilluminators. 500 µL stains 50 minigels. A 1 mL unit size (S-7568) and a special packaging (S-7586) are available....
Company:Molecular Probes (Invitrogen)

SYBR Green II RNA gel stain*10,000X concentrate in DMSO**special packaging* from Molecular Probes (Invitrogen)

Description:is a sensitive nucleic acid gel stain that has bright fluorescence when bound to RNA and low background in gels, making it ideal for use with either formaldehyde/agarose or polyacrylamide gels using laser scanners or standard UV transilluminators. A 500 µL unit size (S-7564) and 1mL unit size (S-7568) are available....
Company:Molecular Probes (Invitrogen)

SYBR Green I nucleic acid gel stain*10,000X concentrate in DMSO* from Molecular Probes (Invitrogen)

Description:This exceptionally sensitive nucleic acid gel stain has bright fluorescence when bound to dsDNA and low background in gels, making it ideal for detecting dsDNA in gels using laser scanners or standard UV transilluminators. has also found uses in capillary electrophoresis, real-time PCR assays and bandshift assays. One mL stains 100 minigels. A 500 µ...
Company:Molecular Probes (Invitrogen)

SYBR Green I nucleic acid gel stain*10,000X concentrate in DMSO**special packaging* from Molecular Probes (Invitrogen)

Description:This exceptionally sensitive nucleic acid gel stain has bright fluorescence when bound to dsDNA and low background in gels, making it ideal for detecting dsDNA in gels using laser scanners or standard UV transilluminators. has also found uses in capillary electrophoresis, real-time PCR assays and bandshift assays. A 500 µL unit size (S-7563) and 1 mL u...
Company:Molecular Probes (Invitrogen)

More>>

SYBR at Biology Technology

Improved Sensitivity for Staining RNA with SYBR Gold Stain

II still video system provides quality images fromnanogram quantities of RNA Genina Troutman Ian Miller Jeff Mueller MikeKobrin Stratagene Gold nucleic acid gel stain(Molecular Probes), combined with Stratagenes Eagle Eye II stillvideo system, allows t...

QuantiTect SYBR Green RT-PCR Kit

In one-step quantification of RNA using the QuantiTect SYBR Green RT-PCR Kit, sensitivity is enhanced by combining HotStarTaq DNA Polymerase with a unique blend of Sensiscript and Omniscript Reverse Transcriptases. Sensiscript RT is designed for use with very small amounts of RNA, while Omnis...

Detection of Genetically Modified Soybean in Processed Foods Using Real-Time Quantitative PCR with SYBR Green I Dye on the DNA Engine Opticon 2 System

MJ Research, Inc., South San Francisco, CA We present a real-time quantitative PCR (qPCR) protocol for the detection and quantitation of soy genetically modified to be resistant to the herbicide glyphosate. The assay utilizes SYBR Green...

Real-Time Quantification of Genomic DNA Using DyNAzyme II DNA Polymerase and SYBR Green I Dye

Mimi Amutan and David Batey, Ph.D. Real-time quantification was performed for lambda and human genomic DNA on the DNA Engine Opticon system (MJ Research). DyNAzyme II DNA polymerase*was used for amplification, and SYBR Green I fluorescent dye was used for detection. The sensitivity and linear dynamic range of...
SYBR at Medicine News
SYBR at Medicine Products
SYBR at Medicine Technology
Other TagsChicagoChicagoCompanyCompanyCompanyCompanyLucigenLucigenBiomedicalBiomedicalMirusMirusBrandingFiservAuroraPatentPatent
(Date:7/25/2008)... The Retina Group of New York will present a...r degeneration especially designed for seniors. Th...ibrary at 116 Merritts Road, Farmingdale, NY 11735...ce is free and refreshments will be provided. The ...0. , Hicksville and Haupp...
(Date:7/25/2008)... The Drug Information Association (DIA) and ...he Critical Path Initiative (CPI) on the Move: Com...da, MD) and the Critical Path Transporter Workshop... Horsham, PA (PRWEB) July 25, 2005-- T...ociation (DIA)] and the Food and Drug Administrati...
(Date:7/25/2008)... Columbus-based law firm represents Pickerin...urchased at Columbus-area Kroger store , ...25, 2008 -- http://www.donaheyohioinjurylawyers.c...sonal injury law firms in central Ohio, has filed ...rt (Case No. 08CV9804) against The Kroger Co., in ...
(Date:7/24/2008)... Hoag to lease hospital facility on Sand Can...h, CA (Vocus) July 24, 2008 -- Hoag Memorial Hospi..., Inc. (NYSE: HCP), a Real Estate Investment Trust...-bed hospital facility on Sand Canyon Avenue near ...lity is currently operated by Tenet Healthcare Cor...
Breaking Medicine News(10 mins):Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 3Health News:DIA And FDA To Host Two Important Critical Path Workshops 2Health News:DIA And FDA To Host Two Important Critical Path Workshops 3Health News:Donahey Law Firm Files E. Coli Product Liability Lawsuit Against Kroger Company in Franklin County Court 2Health News:Hoag Hospital Announces Agreement to Open Irvine Campus 2
(Date:7/24/2008)... , July 24, 2008 A new study by researchers from...alth addresses one of the most challenging issues ...V transmission in poor countries. In these settin... the best outcome for their infants, they should e...g four to six months after birth. But according to...
(Date:7/24/2008)... , Irvine, Calif. UC Irvine researchers have f...ur own body clock and metabolism. The discovery r...etes, obesity and other related diseases. , Paol... of Pharmacology, and his colleagues have identifi...ulates the body,s circadian rhythms, works in bala...
(Date:7/24/2008)... , PORTLAND, Ore. July 23, 2008. A fire is curren... were made about fire behavior about 2 years ago. ...ate-Successional Reserve (LSR) study in the planni...r where the Cold Springs fire is now active., Th...de Range in Washington, and covers about 15,000 ac...
(Date:7/23/2008)... , COLUMBUS, Ohio Wealthy nations willing to col...event the emission of roughly half a billion metri...years, new research suggests. , It would take a...he tropical deforestation in the world, one of the...earchers estimate. , If adopted, this type of pr...
Breaking Biology News(10 mins):Early cessation of breastfeeding by HIV+ women in poor countries and child survival 2Early cessation of breastfeeding by HIV+ women in poor countries and child survival 3Circadian rhythm-metabolism link discovered 2Landscape study may offer solutions for fire managers 2Paying to save tropical forests could be a way to reduce global carbon emissions 2Paying to save tropical forests could be a way to reduce global carbon emissions 3Paying to save tropical forests could be a way to reduce global carbon emissions 4Free White Paper Available for Clinical Laboratory Managers 3A Effectively Isolating Anaerobic Bacteria 2686 1Free White Paper Available for Clinical Laboratory Managers 3A Effectively Isolating Anaerobic Bacteria 2686 2Protalix BioTherapeutics Extends Research Agreement With Yissum Based on Promising Acetylcholinesterase Program Results in Animal Study 1242 1Protalix BioTherapeutics Extends Research Agreement With Yissum Based on Promising Acetylcholinesterase Program Results in Animal Study 1242 2Protalix BioTherapeutics Extends Research Agreement With Yissum Based on Promising Acetylcholinesterase Program Results in Animal Study 1242 3iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product 1239 1iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product 1239 2iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product 1239 3iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product 1239 4Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non Small Cell Lung Cancer 1236 1Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non Small Cell Lung Cancer 1236 2Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non Small Cell Lung Cancer 1236 3Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non Small Cell Lung Cancer 1236 4
Other Contentsrepulsionresolutionresolutionresolutionresolutionresolutionresolutionresolutionresolutionresolutionresponseresponseresponseresponseresponseresponseresponseresponseresponseresponseresponsivenessresponsivenessresponsivenessresponsivenessresponsivenessrestingrestingrestingrestingrestingrestingrestingrestingenzymesenzymesenzymesenzymesenzymesenzymesenzymesenzymeslysatelysatereticulocytereticulocyte